Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters
- PMID: 17361216
- DOI: 10.1038/sj.gt.3302924
Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters
Abstract
In the field of basic and clinical neurosciences, it is important to develop a method for easy delivery and persistent expression of transgene in central neurons. We firstly generated lentiviral vectors with five kinds of neuron-specific promoters, such as synapsin I (SYN), calcium/calmodulin-dependent protein kinase II, tubulin alpha I, neuron-specific enolase and platelet-derived growth factor beta chain promoters and then novel hybrid promoters by fusing cytomegalovirus enhancer (E) to those neuron-specific promoters. Neuron-specific expression of green fluorescent protein (GFP) with those promoters was examined in vivo by injecting the lentiviral vectors into the rat neostriatum, thalamus and neocortex. Among all the promoters, SYN promoter displayed the highest specificity for neuronal expression in all the regions examined (more than 96%). Although GFP production by the hybrid promoters was about 2-4 times larger than the non-enhanced promoters, the neuronal specificity was significantly decreased in most cases. However, the neuronal specificity of E/SYN hybrid promoter exhibited the least decrease only in the thalamus. Furthermore, the transcriptional activity and neuronal specificity of E/SYN promoter were sustained for up to 8 weeks. Thus, lentivirus with E/SYN promoter is the best vector for strong persistent expression in neurons.
Similar articles
-
Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.Gene Ther. 2007 Dec;14(23):1623-31. doi: 10.1038/sj.gt.3303021. Epub 2007 Sep 13. Gene Ther. 2007. PMID: 17851547
-
CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.Gene Ther. 2004 Jan;11(1):52-60. doi: 10.1038/sj.gt.3302126. Gene Ther. 2004. PMID: 14681697
-
GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain.Mol Ther. 2006 Dec;14(6):872-82. doi: 10.1016/j.ymthe.2006.05.020. Epub 2006 Aug 10. Mol Ther. 2006. PMID: 16904943
-
Lentiviral vectors for treating and modeling human CNS disorders.J Gene Med. 2004 Sep;6(9):951-62. doi: 10.1002/jgm.600. J Gene Med. 2004. PMID: 15352068 Review.
-
Gene therapy progress and prospects: Parkinson's disease.Gene Ther. 2003 Sep;10(20):1721-7. doi: 10.1038/sj.gt.3302116. Gene Ther. 2003. PMID: 12939638 Review. No abstract available.
Cited by
-
Nonviral direct conversion of primary mouse embryonic fibroblasts to neuronal cells.Mol Ther Nucleic Acids. 2012 Jul 10;1(7):e32. doi: 10.1038/mtna.2012.25. Mol Ther Nucleic Acids. 2012. PMID: 23344148 Free PMC article.
-
Gene delivery with viral vectors for cerebrovascular diseases.Front Biosci (Elite Ed). 2013 Jan 1;5(1):188-203. doi: 10.2741/e607. Front Biosci (Elite Ed). 2013. PMID: 23276981 Free PMC article. Review.
-
A novel AAV9-dual microRNA-vector targeting GRIK2 in the hippocampus as a treatment for mesial temporal lobe epilepsy.Mol Ther Methods Clin Dev. 2024 Sep 16;32(4):101342. doi: 10.1016/j.omtm.2024.101342. eCollection 2024 Dec 12. Mol Ther Methods Clin Dev. 2024. PMID: 39429724 Free PMC article.
-
Fluorescent Biosensors for Neurotransmission and Neuromodulation: Engineering and Applications.Front Cell Neurosci. 2019 Oct 23;13:474. doi: 10.3389/fncel.2019.00474. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31708747 Free PMC article. Review.
-
The snoRNA MBII-52 regulates cocaine-induced conditioned place preference and locomotion in mice.PLoS One. 2014 Jun 30;9(6):e99986. doi: 10.1371/journal.pone.0099986. eCollection 2014. PLoS One. 2014. PMID: 24979384 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous